Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (4): 924-928    DOI: 10.31083/j.ceog4804146
Original Research Previous articles | Next articles
Comparison of an estradiol patch and GnRH-antagonist protocol with a letrozole/antagonist protocol for patients without oocyte development, fertilization and/or embryo development in previous IVF cycles
Aybike Pekin1, Ayşe Gül Kebapçılar2, Ersin Çintesun2, Setenay Arzu Yılmaz2, Özlem Seçilmiş Kerimoğlu2, *()
1Department of Obstetrics and Gynecology, Mersin Training and Research Hospital, 33240 Toroslar, Mersin, Turkey
2Department of Obstetrics and Gynecology, Faculty of Medicine, Selcuk University, 42100 Selçuklu, Konya, Turkey
Download:  PDF(108KB)  ( 101 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Diminished ovarian reserve (DOR) is a challenge for clinicians in IVF cycles and several treatment modalities have been suggested to improve outcomes. The aim of this study was to compare live birth rates following ovarian stimulation using a luteal phase estradiol (E2)/gonadotropin releasing hormone (GnRH) antagonist protocol (LPG group) with a letrozole/antagonist (LA group) protocol in patients with DOR. Methods: A total of 51 women with DOR, previously canceled IVF cycles and aged 40 years or less were investigated. In the LPG group (n = 26), a transdermal E2 patch was applied every other day starting 10 days after the luteinizing hormone (LH) surge. At day 11 after the LH surge, GnRH antagonists were administered for three consecutive days. In the LA group (n = 25), letrozole (5 mg/day) treatment was begun on the second day of menstruation and administered for 5 consecutive days. In both groups, gonadotropins were initiated on the second day of menstruation. Results for the two groups were compared using chi-square and Student's t-test, as appropriate. Results: Although the initial and total gonadotropin doses were significantly higher in the LPG group, the peak E2 levels, number of oocytes and fertilization rates and cancellation rates were similar. Trends toward improved live birth rates per transfer (23% vs. 11%) and per cycle (11.5% vs. 4%) were seen in the LPG group compared to the LA group, although the differences were not statistically significant. Discussion: DOR patients with previously canceled IVF cycles may be treated with either the LPG or LA protocols.
Key words:  Diminished ovarian reserve      Estradiol patch      Letrozole      GnRH-antagonist protocol     
Submitted:  27 November 2020      Revised:  19 March 2021      Accepted:  31 March 2021      Published:  15 August 2021     
*Corresponding Author(s):  Özlem Seçilmiş Kerimoğlu     E-mail:  ozlemsecilmis@selcuk.edu.tr

Cite this article: 

Aybike Pekin, Ayşe Gül Kebapçılar, Ersin Çintesun, Setenay Arzu Yılmaz, Özlem Seçilmiş Kerimoğlu. Comparison of an estradiol patch and GnRH-antagonist protocol with a letrozole/antagonist protocol for patients without oocyte development, fertilization and/or embryo development in previous IVF cycles. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 924-928.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog4804146     OR     https://ceog.imrpress.com/EN/Y2021/V48/I4/924

[1] Yu Deng, Zhan-Hui Ou, Min-Na Yin, Pei-Ling Liang, Zhi-Heng Chen, Abraham Morse, Ling Sun. Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 835-841.
[2] J.H. Check, D.L. Check, M.P. Dougherty. Marked improvement of the aromatase induced arthralgia syndrome following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 291-292.
[3] J.H. Check, J.R. Liss, D. Check. Influence of the conclusion of a recent large cooperative study in changing standard protocol of inducing menses in anovulatory women with oligomenorrhea prior to initiating ovulation induction with anti-estrogens and outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 180-182.
[4] J. H. Check, J. R. Liss, J. Vaniver. The effect of clomiphene citrate vs. letrozole on post-coital tests[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(2): 184-185.
[5] E. Poli, S. Manfé, D. Capuzzo, S. Gava, F. Viganò, M.L. Coronella, M. Gangemi. DHEA pre-treated patients, poor responders to a first IVF (ICSI) cycle: clinical results[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(1): 5-9.
[6] C. Yasa, E. Bastu, O. Dural, E. Celik, B. Ergun. Evaluation of low-dose letrozole addition to ovulation induction in IVF[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(1): 98-100.
[7] J.H. Check, R. Chern, J. Amui. Successful pregnancy following in vitro fertilization embryo transfer in a 46-year-old woman with diminished oocyte reserve as evidenced by a high day 3 serum estradiol[J]. Clinical and Experimental Obstetrics & Gynecology, 2011, 38(3): 209-210.
No Suggested Reading articles found!